A Novel Nanocapsule Delivery System to Overcome Intestinal Degradation and Drug Transport Limited Absorption of P-glycoprotein Substrate Drugs

被引：0
|
作者：
Taher Nassar
Alona Rom
Abraham Nyska
Simon Benita
机构：
[1] The Hebrew University of Jerusalem,Department of Pharmaceutics, School of Pharmacy
[2] Tel Aviv University,Consultant in Toxicological Pathology, Sackler School of Medicine
来源：
Pharmaceutical Research | 2008年 / 25卷
关键词：
CYP3A; nanocapsules; P-gp; tacrolimus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2019 / 2029
页数：10
相关论文
共 50 条
  • [21] Effects of Polyoxyethylene Alkyl Ethers on the Intestinal Transport and Absorption of Rhodamine 123: A P-glycoprotein Substrate by In Vitro and In Vivo Studies
    Zhao, Wanting
    Uehera, Sachiyo
    Tanaka, Keiichiro
    Tadokoro, Shuhei
    Kusamori, Kosuke
    Katsumi, Hidemasa
    Sakane, Toshiyasu
    Yamamoto, Akira
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 105 (04) : 1526 - 1534
  • [22] Effects of Labrasol and other pharmaceutical excipients on the intestinal transport and absorption of rhodamine123, a P-glycoprotein substrate, in rats
    Lin, Yulian
    Shen, Qi
    Katsumi, Hidemasa
    Okada, Naoki
    Fujita, Takuya
    Jiang, Xuehua
    Yamamoto, Akira
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2007, 30 (07) : 1301 - 1307
  • [23] A novel EPR approach to determine the mechanism of drug transport by P-glycoprotein
    Al-Shawi, MK
    Omote, H
    BIOPHYSICAL JOURNAL, 2002, 82 (01) : 563A - 563A
  • [24] Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery
    Hebert, MF
    ADVANCED DRUG DELIVERY REVIEWS, 1997, 27 (2-3) : 201 - 214
  • [25] Enhanced Oral Absorption of Paclitaxel in a Novel Self-Microemulsifying Drug Delivery System with or Without Concomitant Use of P-Glycoprotein Inhibitors
    Shicheng Yang
    R. Neslihan Gursoy
    Gregory Lambert
    Simon Benita
    Pharmaceutical Research, 2004, 21 : 261 - 270
  • [26] Enhanced oral absorption of paclitaxel in a novel self-microemulsifying drug delivery system with or without concomitant use of P-glycoprotein inhibitors
    Yang, SC
    Gursoy, RN
    Lambert, G
    Benita, S
    PHARMACEUTICAL RESEARCH, 2004, 21 (02) : 261 - 270
  • [27] Brij-functionalized chitosan nanocarrier system enhances the intestinal permeability of P-glycoprotein substrate-like drugs
    Wei Xiong
    Shi Hang Xiong
    Qi Ling Chen
    Ke Gang Linghu
    Guan Ding Zhao
    Chu, John M. T.
    Wong, Gordon T. C.
    Juan Li
    Yuan Jia Hu
    Yi Tao Wang
    Hua Yu
    CARBOHYDRATE POLYMERS, 2021, 266
  • [28] The Effects of PLGA Microparticles on Intestinal Absorption of P-glycoprotein Substrate Using the Everted Rat Intestinal Sac Model
    Derakhshandeh, Katayoun
    Hosseinalizadeh, Aidin
    Nikmohammadi, Maryam
    ARCHIVES OF PHARMACAL RESEARCH, 2011, 34 (11) : 1989 - 1997
  • [29] The effects of PLGA microparticles on intestinal absorption of p-glycoprotein substrate using the everted rat intestinal sac model
    Katayoun Derakhshandeh
    Aidin Hosseinalizadeh
    Maryam Nikmohammadi
    Archives of Pharmacal Research, 2011, 34 : 1989 - 1997
  • [30] Circadian changes in intestinal secretion: Drug-drug interactions with the P-glycoprotein (P-gp) substrate talinolol
    Okyar, A.
    Baktir, G.
    Spahn-Langguth, H.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2008, 377 : 62 - 62
12345